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Enantiopure 3-methyl-3,4-dihydroisocoumarins and 3-methyl-1,2,3,4-
tetrahydroisoquinolines via chemoenzymatic asymmetric transformationsw
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A new divergent and asymmetric synthetic route has been developed for the production of
enantiomerically pure isocoumarin and isoquinoline derivatives. Stereoselective formation of
2-(2-hydroxypropyl)benzonitriles has been identiﬁed as the key step. Rhizomucor miehei lipase has
displayed from moderate to excellent selectivities in the acetylation of its (R)-enantiomers, while
ADH-A from Rhodococcus ruber catalyzed the bioreduction of the corresponding ketones with
excellent activities and stereopreferences. Enantiopure alcohols obtained in this manner have been
used for the straightforward synthesis of a series of 3-methyl-3,4-dihydroisocoumarins and
3-methyl-1,2,3,4-tetrahydroisoquinolines with good overall yields.
Introduction
The development of new strategies in heterocyclic chemistry
continues to be an attractive and challenging task for synthetic
chemists. In this context, the preparation of 3,4-dihydro-
isocoumarins has been gathering increasing attention in recent
years because of their structural implications as basic scaﬀolds
in alkaloids and many natural products1 that exhibit a broad
range of biological activities. Both non-asymmetric and stereo-
selective methods for the preparation of this family of
oxygenated compounds have been extensively reported in
recent years.2 In addition, dihydroisocoumarins are a class
of naturally occurring biologically active lactones possessing
remarkable antibacterial, anticancer, antifungal or antimalarial
properties.3 Asymmetric synthesis and isolation from plant extracts
of 3-substituted-3,4-dihydroisocoumarins have particularly
attracted attention.4 However, only a few chemoenzymatic
routes have been reported until now, among which biocatalytic
methods for the preparation of 3-methyl-3,4-dihydroisocoumarins
only include chemoenzymatic pathways involving ketone
transformations such as Baeyer–Villiger oxidations5 or bioreduction
processes.6
Here we describe for the ﬁrst time a divergent synthetic
approach for the production of 3-methyl-3,4-dihydroiso-
coumarins and 3-methyl-1,2,3,4-tetrahydroisoquinolines starting
from readily commercially available 2-bromobenzonitriles.
The asymmetric actions of several lipases and alcohol dehydro-
genases (ADHs) have been considered in the search for the optimal
production of enantiopure 2-(2-hydroxypropyl)benzonitriles, which
have shown an excellent versatility as key intermediates for the
preparation of the target molecules.
Results and discussion
Hydrolase-catalyzed kinetic resolution7 and dynamic kinetic
resolution8 of racemic 1-phenylpropan-2-ols have been widely
reported through acylation processes using a variety of acyl donors
and biocatalysts. In spite of the fact that lipases act with a diﬀerent
degree of selectivity in the resolution of 1-phenylpropan-2-ols,9
their action towards 2-(2-hydroxypropyl)benzonitriles still
remains unexplored. The reaction of commercially available
2-bromobenzonitrile (1a) with a solution of butyl lithium in
THF as solvent, followed by the addition of propylene oxide
in the presence of boron triﬂuoride etherate, aﬀorded racemic
2-(2-hydroxypropyl)benzonitrile (2a) in 71% yield (Scheme 1).
The lipase-catalyzed kinetic resolution of ()-2a was then
analyzed using 3 equiv. of vinyl acetate and variable biocatalyst
loadings and solvents at 30 1C.Candida cylindracea lipase (CCL),
porcine pancreas lipase (PPL), lipase AK from Pseudomonas
ﬂuorescens, Thermomyces lanuginosa lipase (TLL) and alcalase
CLEA all displayed very low conversions and poor enantio-
discrimination values, while Candida antarctica lipase type A
(CAL-A), Candida antarctica lipase type B (CAL-B) and
Burkholderia cepacia lipase (PSL-IM) led to higher reactivities,
with close to 50% conversion, but very poor selectivities (Eo 20).
However, the use of Rhizomucor miehei lipase (RML IM) as a
biocatalyst led to excellent enantioselectivities (E>150) at diﬀerent
temperatures and variable protein loadings (Table 1, entries 1–3).
Optimal results were found when using a substrate : enzyme ratio
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of 1 : 2 at 30 1C, with both substrate and product being
recovered in 96% ee after 8 h (entry 3). Similar results
in terms of excellent selectivities were achieved with other
solvents, such as 1,4-dioxane, THF, toluene or vinyl acetate as
both solvent and acyl donor, although with a lower reactivity
(entries 4–7).
To examine the scope of RML IM lipase, the kinetic resolution
of the substituted benzene derivatives 2b–f was studied. Racemic
alcohols 2b–e were prepared in moderate to high yields using an
identical synthetic approach. However, for the 4-ﬂuorinated deri-
vative 1f, 2-bromo-4-ﬂuoro-3-(2-hydroxypropyl) benzonitrile was
isolated as the unique reaction product due to the ﬂuorine
promoted metallation at the C3-position.11 The use of Et2O
instead of THF as reaction medium led to the bromine–lithium
exchange, the desired alcohol 2f being obtained in 73% isolated
yield. Lipase-catalyzed acetylation led to the production of all the
acetates (R)-3b–f in a range between 92 and 99% ee using TBME
as solvent (entries 8–12). However only non-substituted alcohol 2a
(entry 3, E= 194) and 4-substituted 2b,f (E> 200, entries 8 and
12) were acetylated with very good to excellent enantioselectivities.
On the other hand, the 5-substituted 2c,d (entries 9 and 10)
and the 3-methylated substrate 2e (entry 11) led to moderate
selectivities, the reaction rate being much lower for 2e, which
posses the substitution closer to the reacting centre.
In order to improve the synthetic access to enantiopure
precursors of 3-methyl-3,4-dihydroisocoumarins, and motivated
by the high potential shown by redox enzymes in the bioreduction
of 1-aryl-2-propanones,12 we decided to explore the potential of
alcohol dehydrogenases for the production of enantioenriched
2a–f. To do this, racemic alcohols 2a–f were chemically oxidized,
the bioreduction of the ketones 4a–f obtained in this way was then
studied. The Dess–Martin reagent was chosen to perform the
chemical oxidations due to the mild conditions required, aﬀording
4a–f in good yields (Scheme 2).
A series of ADHs were tested for the bioreduction of 4a,
including alcohol dehydrogenases from Rhodococcus ruber
(ADH-A), Candida parapsilosis (ADH-CP) or Lactobacillus
keﬁr (ADH-LK), and also the very well known Baker’s
yeast.13 Initial experiments were carried out in the mg-scale,
obtaining alcohol (S)-2a in high to excellent enantiomeric
excess, except for the reaction with ADH-LK which, following
the anti-Prelog stereoselectivity rule, led to the opposite
enantiomer (Table 2, entries 1–4). On the basis of these results,
and bearing in mind the scaling-up of the biocatalytic processes
for further synthetic applications, ADH-A overexpressed in
E. coli was successfully applied in the bioreduction of 4a,
yielding identical results to those of commercially available
ADH-A (entry 5).
Using our knowledge of the best reaction conditions, an
extension of this enzymatic study was done for substituted
ketones 4b–f. The formation of the enantiopure (S)-alcohols in
complete conversion was detected after 24 h for all the
substrates, with the exception of the bioreduction of the
3-methyl derivative (4e), which reached 49% conversion (data
not shown). This may be explained by the hindering eﬀect of
the methyl group which is very close to the carbonyl group.
Biocatalytic reactions were subsequently scaled-up to 80 mg of
substrate. In all cases complete conversions (entries 6–11) were
obtained, longer reaction times (72 h) only being required for
ketone 4e (entry 10). Finally, the intramolecular cyclisation of
alcohols (S)-2a–f in acidic medium led to the enantiopure
3-methyl-3,4-dihydroisocoumarins (S)-5a–f after puriﬁcation
by extraction with CH2Cl2 (65–90%).
14
In order to expand the applicability of these enantiomerically
pure alcohol intermediates, we decided to move towards
the asymmetric synthesis of structurally similar compounds.
The possibility of using the same alcohol precursors highlights
the importance of this divergent synthetic approach, especially
Scheme 1 Chemical synthesis and kinetic resolution of racemic alcohols 2a–f using Rhizomucor miehei lipase.
Table 1 Lipase-catalyzed kinetic resolution of 2-(2-hydroxypropyl)benzonitriles 2a–f using vinyl acetate as an acyl donor
Entry Substrate RML IM : 2a–fa T/1C Solvent t/h eep
b (%) ees
b (%) cc (%) Ed
1 2a 1 : 1 30 TBME 23 99 63 39 >200
2 2a 1 : 1 45 TBME 8 >99 35 26 >200
3 2a 2 : 1 30 TBME 8 96 96 50 194
4 2a 2 : 1 30 1,4-Dioxane 23 >99 32 24 >200
5 2a 2 : 1 30 THF 23 >99 14 12 >200
6 2a 2 : 1 30 Toluene 23 98 85 47 >200
7 2a 2 : 1 30 Vinyl acetate 23 98 44 31 153
8 2b (R = 4-Me) 2 : 1 30 TBME 8 96 99 51 >200
9 2c (R = 5-OMe) 2 : 1 30 TBME 24 92 80 47 59
10 2d (R = 5-Me) 2 : 1 30 TBME 9 95 61 39 73
11 2e (R = 3-Me) 2 : 1 30 TBME 9 94 20 17 39
12 2f (R = 4-F) 2 : 1 30 TBME 24 99 57 37 >200
a Ratio enzyme : substrate in weight (w/w). b Enantiomeric excesses of product (eep) and substrate (ees) determined by HPLC.
c Conversion values
calculated as c = ees/(ees + eep).
d Enantiomeric ratio calculated as E = ln[(1  ees)/1 + (ees/eep)]/ln[(1 + ees)/1 + (ees/eep)].10
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when the desired targets are isoquinoline derivatives, a class of
nitrogenated compounds that are widely distributed in Nature
and show a potent physiological action.15 As a result of their
importance, a number of research groups have reported the
asymmetric synthesis of isoquinoline derivatives.16 Biocatalytic
production of these derivatives is nowadays mainly based upon
lipase-catalyzed kinetic resolution,17 bioreduction of cyclic imines
with metalloenzymes18 or deracemisation experiments using
evolved monoamine oxidases combined with non-selective reducing
agents.19 However, little attention has been paid to the asymmetric
synthesis of 3-substituted tetrahydroisoquinolines,20 a class of
compounds that not only shows remarkable biological activity21
but also oﬀers practical applications in asymmetric catalysis.22
Taking advantage of the versatility of (S)-2a–f, our aim was
to design a general synthetic pathway for the synthesis of
3-methyl-1,2,3,4-tetrahydroisoquinolines. To do this, alcohols
were mesylated in dichloromethane at room temperature, and
then diﬀerent methods to reduce the nitrile group were attempted.
The mild reduction procedure with NiCl2–NaBH4,
23 followed by
an in situ protection of the amine formed, was found to be an
ideal strategy for the preparation of the diprotected compounds
(S)-7a–f (Scheme 3). The intramolecular cyclisation of (S)-7a–f
in the presence of cesium carbonate yielded enantiopure
N-Boc amines (R)-8a–f, a minimum presence of the corre-
sponding tert-butyl 2-((1E)-prop-1-en-1-yl)benzyl carbamates
(2–10%) being observed in all cases. The chromatographic
puriﬁcation of the reaction crudes aﬀorded the N-protected
amines 8a–d in moderate yield.
However, the N-Boc tetrahydroisoquinolines 8e,f decomposed
in silica gel, so further transformations were required for the
isolation of these amines. Then, (R)-8e,f were chemically
deprotected with triﬂuoroacetic acid in dichloromethane,
yielding (R)-9e in 47% overall yield after ﬂash chromatography.
Puriﬁcation of (R)-9f proved unsuccessful, since it shows a high
instability in the chromatographic puriﬁcation step. To avoid
this drawback we designed an alternative procedure using
p-nitrobenzaldehyde as a scavenger for the remaining amounts
of 1-(2-((1E)-prop-1-en-1-yl)-p-ﬂuorophenyl)methanamine,
followed by an extraction puriﬁcation step aﬀording (R)-9f
in high chemical purity and low yield. In order to conﬁrm the
absolute conﬁguration of the ﬁnal products, we have synthesized
(R)-3-methyl-1,2,3,4-tetrahydroisoquinoline (9a) from 8a. The
optical rotation value is in concordance with previously
published data for (R)-9a.24
Conclusions
2-(2-Hydroxypropyl)benzonitriles have been found to be adequate
building blocks in the divergent asymmetric synthesis of
enantiopure substituted 3-methyl-3,4-dihydroisocoumarins
and 3-methyl-1,2,3,4-tetrahydroisoquinolines. Rhizomucor
miehei lipase has displayed the best results in the lipase-
catalyzed acetylation of racemic alcohols. However, enantio-
selectivity was found to be highly dependent on the ring pattern
substitution, with moderate stereoselectivities being found for
3- and 5-monosubstituted alcohols, and very high to excellent
values being achieved with none or 4-substituted derivatives.
The chemical oxidation of racemic alcohols and subsequent
bioreduction of the related ketones provided access to a series
of novel enantiopure 2-(2-hydroxypropyl)benzonitriles, ADH-A
Scheme 2 Chemoenzymatic synthesis of 3-methyl-3,4-dihydroisocoumarins through bioreduction processes.
Table 2 Bioreduction of ketones 4a–f in aqueous medium at 30 1C
and 250 rpm
Entry Ketone ADHa t/h eep
b (%) cc (%)
1 4a ADH-A 24 >99 >97
2 4a Baker’s yeast 24 96 >97
3 4a ADH-CP 24 >99 >97
4 4a ADH-LK 24 98 38
5 4a E. coli/ADH-A 24 >99 >97
6d 4a E. coli/ADH-A 24 >99 >97 (>97)
7d 4b E. coli/ADH-A 24 >99 >97 (93)
8d 4c E. coli/ADH-A 24 >99 >97 (>97)
9d 4d E. coli/ADH-A 24 >99 >97 (82)
10d 4e E. coli/ADH-A 72 >99 >97 (62)
11d 4f E. coli/ADH-A 24 >99 >97 (77)
a (S)-Alcohols 2a–f were obtained as ﬁnal products with the exception
of the bioreduction of 4a with ADH-LK. b Determined by HPLC.
c Determined by GC. d Reactions in 80 mg scale of substrate. Isolated
yields in brackets.
Scheme 3 Chemoenzymatic synthesis of 3-methyl-1,2,3,4-tetrahydroisoquinolines.
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from Rhodococcus ruber being found as an excellent asymmetric
biocatalyst for this reduction step. The enantiopure alcohols so
obtained were treated in acidic medium, leading to a family of
substituted (S)-3-methyl-3,4-dihydroisocoumarins in moderate to
very high yield by intramolecular cyclisation. Taking advantage of
their versatility, alcohol precursors were used in the synthesis of
enantiopure N-Boc-3-methyl-1,2,3,4-tetrahydroisoquinolines
through a three-step synthesis in a very straightforward manner
and without loss of the optical purity.
Experimental
General procedure for the synthesis of 2-(2-hydroxypropyl)-
benzonitriles 2a–f
To a solution of the corresponding commercially available
2-bromobenzonitriles 1a–f (1 equiv.) in THF (or Et2O for 1f,
0.2 M), BuLi (1.1 equiv., 1.6 M in hexane) was added dropwise
at 78 1C under an inert atmosphere. The solution was stirred for
30 min at78 1C and then, propylene oxide (1.5 equiv.) and boron
triﬂuoride etherate (1.5 equiv.) were added dropwise. The mixture
was stirred at 78 1C for additional 1 h, until the reaction
was quenched with water. The mixture was extracted with Et2O
(3 20 mL), organic layers were collected, dried over Na2SO4, and
the solvent evaporated under reduced pressure. The resulting crude
was puriﬁed by ﬂash chromatography (50% Et2O/hexane),
obtaining the corresponding alcohols 2a–f in high yields (69–84%).
General procedure for the synthesis of racemic
1-(2-cyanophenyl)propan-2-yl acetates 3a–f
To a solution of the corresponding racemic alcohols 2a–f (1 equiv.)
in dry CH2Cl2 (0.1 M), triethylamine (3 equiv.), 4-(N,N-dimethyl-
amino)pyridine (0.3 equiv.) and acetic anhydride (2 equiv.) were
successively added at rt under an inert atmosphere. The mixture
was stirred and the reaction monitored by TLC analysis (50%
Et2O/hexane) until no starting material was detected (30–60 min).
Solvent was evaporated afterwards and the crude puriﬁed by ﬂash
chromatography (50% Et2O/hexane), obtaining the corresponding
1-(2-cyanophenyl)propan-2-yl acetates 3a–f in high to excellent
yields (82–98%).
General procedure for the synthesis of 2-(2-oxopropyl)-
benzonitriles 4a–f
To a solution of the corresponding racemic alcohols 2a–f
(1 equiv.) in CH2Cl2 (0.1 M), the Dess–Martin reagent (1.5 equiv.)
was added at rt under an inert atmosphere. The mixture was
stirred for 4 h. Then, the reaction was quenched with an aqueous
saturated 1 : 1 solution of Na2S2O3–NaHCO3. The mixture was
extracted afterwards with CH2Cl2, organic layers were collected,
dried over Na2SO4, ﬁltered, and the solvent evaporated under
reduced pressure. The resulting crude was puriﬁed by ﬂash
chromatography (50%Et2O/hexane), aﬀording the corresponding
ketones 4a–f in high yields (70–81%).
General procedure for the synthesis of 3-methylisochroman-1-
ones 5a–f
The corresponding alcohols 2a–f (1 equiv.) were dissolved in a 1 : 1
solution of MeOH and hydrochloric acid (37%) (0.02 M). The
solution was warmed to 66 1C and stirred overnight under reﬂux.
The reaction was quenched with water and extracted with
CH2Cl2 (3  10 mL). Organic layers were collected, dried over
Na2SO4, ﬁltered and the solvent evaporated under reduced
pressure, aﬀording the corresponding lactones 5a–f without
further puriﬁcation in high yields (71–90%).
General procedure for the synthesis of 1-(2-cyanophenyl)propan-
2-yl methanesulfonates 6a–f
To a solution of the corresponding alcohols 2a–f (1 equiv.) in
CH2Cl2 (0.1 M), triethylamine (2 equiv.), 4-(N,N-dimethylamino)-
pyridine (0.1 equiv.) and methanesulfonyl chloride (2 equiv.) were
successively added under an inert atmosphere. The reaction was
stirred overnight at rt and then the solvent evaporated under
reduced pressure. The resulting crude was puriﬁed by ﬂash
chromatography (50% Et2O/hexane), to aﬀord the corresponding
1-(2-cyanophenyl)propan-2-yl methanesulfonates 6a–f in good
yields (82–96%).
General procedure for the synthesis of
1-[2-(((tert-butoxycarbonyl)amino)methyl)phenyl]propan-2-yl
methanesulfonates 7a–f
To a solution of the corresponding 1-(2-cyanophenyl)propan-2-yl
methanesulfonates 6a–f (1 equiv.) in MeOH (0.13 M), NiCl2
6H2O (0.1 equiv.), di-tert-butyldicarbonate (2 equiv.) were added
under an inert atmosphere. Then, the mixture was cooled to 0 1C
and NaBH4 (7 equiv.) was added in small portions over 15 min.
The reaction was warmed to rt afterwards and stirred for 4 h. Then,
the solution was ﬁltered over Celites, the solvent evaporated under
reduced pressure and the resulting crude puriﬁed by ﬂash
chromatography (50% Et2O/hexane), aﬀording the corre-
sponding protected amines 7a–f with good yields (70–82%).
General procedure for the synthesis of tert-butyl 3-methyl-3,4-
dihydroisoquinoline-2(1H)-carboxylates 8a–d
To a solution of the corresponding 1-[2-(((tert-butoxycarbonyl)a-
mino)methyl)phenyl]propan-2-yl methanesulfonates 7a–d (1 equiv.)
in dry MeCN (0.1 M), cesium carbonate was added (10 equiv.)
under an inert atmosphere. The mixture was stirred at 82 1C for
2 days. Then, water was added and the reaction extracted with
CH2Cl2 (3  10 mL), organic layers were collected, dried over
Na2SO4, ﬁltered, and the solvent evaporated under reduced
pressure. The resulting crude was puriﬁed by ﬂash chromato-
graphy (5%EtOAc/hexane), aﬀording the corresponding tert-butyl
3-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylates 8a–d in
good yields (55–62%).
General procedure for the synthesis of
3-methyltetrahydroisoquinolines 9a,e
To a solution of the corresponding 1-[2-(((tert-butoxycarbonyl)-
amino)methyl)phenyl]propan-2-yl methanesulfonates 7a,e (1 equiv.)
in dry MeCN (0.1 M), cesium carbonate was added (10 equiv.)
under an inert atmosphere. The mixture was stirred at 82 1C
for 2 days. Then, water was added and the reaction extracted
with CH2Cl2 (3  10 mL), organic layers were collected, dried
over Na2SO4, ﬁltered, and the solvent was evaporated under
reduced pressure. The mixture was then dissolved in a 1 : 1
mixture of CH2Cl2 and TFA (0.025 M), stirred for 2 h, and
then basiﬁed with NaOH (3 N) and extracted with CH2Cl2.
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Organic layers were collected, dried over Na2SO4, ﬁltered, the
solvent was evaporated under reduced pressure, and the resulting
crude puriﬁed by ﬂash chromatography (10% MeOH/CH2Cl2),
aﬀording the corresponding 3-methyltetrahydroisoquinolines
9a,e in moderate global yields for the two steps (47–54%).
General procedure for the synthesis of (R)-6-ﬂuoro-3-methyl-
1,2,3,4-tetrahydroisoquinoline 9f
To a solution of (S)-1-(2-(((tert-butoxycarbonyl)amino)-
methyl)-5-ﬂuorophenyl)propan-2-yl methanesulfonate 7f (53 mg,
0.15 mmol) in dry MeCN (1.5 mL), cesium carbonate was added
(478 mg, 1.46 mmol) under an inert atmosphere. The mixture was
stirred at 82 1C for 2 days. Then, water was added and the reaction
extracted with CH2Cl2 (3  15 mL), organic layers were collected,
dried over Na2SO4, ﬁltered, and the solvent evaporated under
reduced pressure. The resulting crude was then dissolved in
CH2Cl2 (2 mL) and TFA (2 mL) was added. The mixture was
stirred for 2 h at rt, and then basiﬁed with NaOH (3 N), and
extracted with CH2Cl2 (3 15 mL). Organic layers were collected,
dried over Na2SO4, ﬁltered and the solvent evaporated under
reduced pressure. The mixture was then dissolved in CH2Cl2
(10 mL) and 4-nitrobenzaldehyde (15 mg, 0.10 mmol) andMgSO4
(100 mg, 0.83 mmol) were added. The mixture was stirred for
30 min. Then, the mixture was extracted with a pH 4.5 NaOAc/
HCl buﬀer (30 mL). The aqueous phase was afterwards basiﬁed
with NaOH (3 N) and extracted with CH2Cl2 (3  10 mL).
Organic layers were collected, dried over Na2SO4, ﬁltered, and the
solvent evaporated under reduced pressure, aﬀording pure 9f in
low yield (6 mg, 25%).
General procedure for the lipase mediated kinetic resolution of
alcohols 2a–f
To a suspension of racemic alcohols 2a–f (0.2 mmol, 1 equiv.)
and the adequate lipase in dry solvent (2 mL), vinyl acetate
(55 mL, 0.6 mmol) was added under an inert atmosphere. The
reaction was shaken at 30 1C and 250 rpm, taking regularly
aliquots that were analyzed by HPLC until around 50%
conversion was reached. Then the reaction was stopped, and
the enzyme ﬁltered with CH2Cl2 (3  10 mL). The solvent was
evaporated and the crude of the reaction puriﬁed by ﬂash
chromatography on silica gel (50% Et2O/hexane), obtaining
the corresponding enantiomerically enriched acetates (R)-3a–f
and the alcohols (S)-2a–f (see Table 1 for additional details).
General procedure for the bioreduction of ketones 4a–f with
ADHs
Diﬀerent protocols were used depending on the enzyme and
have been listed below. See Table 2 for additional details.
Bioreduction of 4a–f with ADH-A. In an eppendorf tube
containing the corresponding ketone (2 mg) in TRIS–HCl
50 mM pH 7.5 buﬀer (325 mL), isopropyl alcohol (25 mL),
50 mL of a NADH 10 mM solution in TRIS–HCl buﬀer and
100 mL of an ADH-A solution (3 U) were successively added.
Reaction was shaken at 250 rpm and 30 1C for 24 h. Then, the
mixture was extracted with EtOAc (2 500 mL) and dried over
Na2SO4, analyzing the reaction crude by GC (conversion) and
HPLC (enantiomeric excess).
Bioreduction of 4a with Baker’s yeast. Baker’s yeast (2.2 g)
was added to a solution of glucose (282 mg) in H2O (19 mL)
stirring the resulting suspension for 15 min at 30 1C and 250 rpm.
After this time the corresponding ketone 4a (0.29 mmol) was
added and the suspension was stirred at 30 1C and 250 rpm. Then
the reaction was centrifuged and the supernatant extracted with
Et2O (3  20 mL). Organic phases were combined, dried over
Na2SO4, ﬁltered and the solvent evaporated under reduced
pressure aﬀording a reaction crude containing alcohol (S)-2a.
Bioreduction of 4a with ADH-CP. In an eppendorf tube
containing 4a (2 mg, 0.012 mmol) in TRIS–HCl 50 mM pH 7.5
buﬀer (425 mL), isopropyl alcohol (25 mL), 50 mL of a NADH
10mM solution in TRIS–HCl buﬀer and 7.5 mL of ADH-CP (3 U)
were successively added. Reaction was shaken at 250 rpm
and 30 1C for 24 h. Then, the mixture was extracted with EtOAc
(2  500 mL) and dried over Na2SO4, analyzing the reaction crude
by GC (conversion) and HPLC (enantiomeric excess).
Bioreduction of 4a with ADH-LK. In an eppendorf tube
containing 4a (2 mg, 0.012 mmol) in TRIS–HCl 50 mM pH 7.5
buﬀer (450 mL), 20 mL of glucose-6-phosphate, 10 mL of glucose
6-phosphate dehydrogenase (3 U), 50 mL of a NADPH 10 mM
solution in TRIS–HCl buﬀer and 2 mg of ADH-LK (3 U) were
successively added. Reaction was shaken at 250 rpm and 30 1C for
24 h. Then, the mixture was extracted with EtOAc (2  500 mL)
and dried over Na2SO4, analyzing the reaction crude by GC
(conversion) and HPLC (enantiomeric excess).
Bioreduction of 4a–f with ADH-A overexpressed in E. coli. 15 mg
of E. coli/ADH-A cells (15 mg) were rehydrated in TRIS–HCl
50 mM pH 7.5 buﬀer (500 mL) inside an eppendorf tube. The
mixture was shaken at 250 rpm for 30 min. Then, the corre-
sponding ketones 4a–f (2 mg), isopropyl alcohol (30 mL) and
NADH 10 mM solution (60 mL) were added. The reaction was
shaken at 250 rpm and 30 1C for 24 h, analyzing the reaction crude
by GC (conversion) and HPLC (enantiomeric excess).
Scale up bioreduction of ketones 4a–f with E. coli-ADH-A.
To a solution containing rehydrated E. coli-ADH-A cells
(150 mg) in TRIS–HCl 50 mM pH 7.5 buﬀer (5 mL), isopropyl
alcohol (300 mL), NADH 10 mM in TRIS–HCl 50 mM pH 7.5
solution (600 mL) and the corresponding ketones 4a–f (80 mg)
were successively added. The reaction was shaken until no starting
material was detected by GC analysis. Then, the mixture was
extracted with Et2O (3  10 mL), organic layers were combined,
dried over Na2SO4, ﬁltered and the solvent removed under
reduced pressure, aﬀording the corresponding alcohols (S)-2a–f
in excellent yields without further puriﬁcation.
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